Ticker Hub
TOVX — AI Analysis & Sentiment
4 recent AI-generated analyses for TOVX. Sentiment and confidence insights updated continuously.
Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026
Theriva Biologics' announcement of positive Phase 2b VCN-01 data for pancreatic cancer, to be presented at AACR, marks a significant de-risking eve...
Apr 18, 2026Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del ejercicio 2025
Theriva Biologics' 2025 financial results, including an likely extended cash runway, provide critical short-term stability for its clinical develop...
Mar 13, 2026Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
Theriva Biologics has significantly de-risked its financial position by extending its cash runway into Q1 2027 through a key licensing deal and cap...
Mar 12, 2026Theriva™ Biologics concede la licencia de SYN-020 a Rasayana Therapeutics para numerosas indicaciones
Theriva Biologics secured a licensing deal for SYN-020, offloading development costs and gaining significant potential payments, which materially i...
Feb 18, 2026